ZWILCH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.521200E-01
Normal-vs-Stage2
6.612600E-01
Normal-vs-Stage3
4.735400E-01
Normal-vs-Stage4
9.717600E-01
Stage1-vs-Stage2
4.837800E-01
Stage1-vs-Stage3
6.306200E-01
Stage1-vs-Stage4
9.712400E-01
Stage2-vs-Stage3
2.494600E-01
Stage2-vs-Stage4
5.921200E-01
Stage3-vs-Stage4
5.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.502400E-01
Normal-vs-AfricanAmerican
9.576200E-01
Normal-vs-Asian
9.933800E-01
Caucasian-vs-AfricanAmerican
7.053200E-01
Caucasian-vs-Asian
5.419800E-01
AfricanAmerican-vs-Asian
9.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.352800E-01
Normal-vs-Female
6.899400E-01
Male-vs-Female
4.436800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.875200E-01
Normal-vs-Age(41-60Yrs)
6.240000E-01
Normal-vs-Age(61-80Yrs)
8.325600E-01
Normal-vs-Age(81-100Yrs)
8.814600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.400200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.312600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.063400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.066800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.895000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.538200E-01
Normal-vs-Daily Drinker
9.008800E-01
Normal-vs-Weekly Drinker
3.214400E-01
Normal-vs-Occasional Drinker
8.150800E-01
Normal-vs-Social Drinker
6.465800E-01
Non Drinker-vs-Daily Drinker
5.192400E-01
Non Drinker-vs-Weekly Drinker
4.239400E-01
Non Drinker-vs-Occasional Drinker
8.722200E-01
Non Drinker-vs-Social Drinker
5.869000E-01
Daily Drinker-vs-Weekly Drinker
2.720600E-01
Daily Drinker-vs-Occasional Drinker
4.933000E-01
Daily Drinker-vs-Social Drinker
2.974000E-01
Weekly Drinker-vs-Occasional Drinker
5.018400E-01
Weekly Drinker-vs-Social Drinker
6.418800E-01
Occasional Drinker-vs-Social Drinker
7.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.395800E-01
Normal-vs-Grade 2
7.122600E-01
Normal-vs-Grade 3
7.245200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.241000E-03
Grade 1-vs-Grade 3
1.204210E-03
Grade 1-vs-Grade 4
6.395800E-01
Grade 2-vs-Grade 3
5.655200E-01
Grade 2-vs-Grade 4
7.122600E-01
Grade 3-vs-Grade 4
7.245200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.580000E-01
Normal-vs-NonDiabetic
7.932400E-01
Diabetic-vs-NonDiabetic
3.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.449200E-01
Normal-vs-NoPancreatitis
8.461600E-01
Pancreatitis-vs-NoPancreatitis
4.587600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.354400E-01
Normal-vs-N1
6.423000E-01
N0-vs-N1
1.658420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.891400E-01
Normal-vs-TP53-NonMutant
9.053800E-01
TP53-Mutant-vs-TP53-NonMutant
4.220100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
